Although in my years as a stem cell biologist I haven’t yet been in a leadership role at the International Society for Stem Cell Research or ISSCR, unproven stem cell clinics have claimed that I somehow speak for ISSCR. I am just a standard member of the group like thousands of other researchers. In fact, […]
Recommended reads: ISSCR guidelines pushback, TB outbreak from regen product, pubs Read More »
To get at addressing what’s the real deal on the idea of cellular therapies for COVID-19, I did a short email Q&A interview with Dr. Sean Morrison. Sean is Chair of the Public Policy Committee at ISSCR and Director of Children’s Research Institute at UT Southwestern. He was also President of ISSCR in 2015-2016, and
Interview with Sean Morrison on cellular therapies for COVID-19 Read More »
One of the highlights of Day 1 of #ISSCR2018 for me so far was the talk by Lorenz Studer (Co-Founder of BlueRock) on the use of human embryonic stem cell (HESC)-derived dopamine neurons for Parkinson’s Disease. Note that for this post and if I have time any others on this meeting, they are probably going
Lorenz Studer on Day 1 #ISSCR2018: HESC-based therapies for Parkinson’s Disease Read More »
Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings. Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the
5 big picture stem cell trends at ISSCR 2016 Read More »
Yesterday at ISSCR 2016, Fiona Watt gave a great talk about plasticity of epidermal stem cells. As with my other #ISSCR2016 posts, this one is a stream of impressions, quotes, and key points. For my other blog posts from the meeting see here. First she provided a nice overview of human skin architecture and regulation. The
Fiona Watt excellent talk on epidermal stem cell plasticity ISSCR 2016 Read More »
The second day of ISSCR 2016 started off with a great session on pluripotency and plasticity, and the first talk was by Shinya Yamanaka. He changed the title of his talk to “Reprogramming of Cells and Scientist”. As with my other posts on this meeting, this one is a stream of quotes and impressions from
Shinya Yamanaka at ISSCR 2016 on reprogramming of cells & scientists Read More »
ISSCR 2016’s first plenary session is focused on stem cells & cancer. I was really excited about this one even before the meeting as this topic is a major focus of my own lab. Here’s the lineup for this plenary with great expertise in stem cells & cancer from across the globe: President’s Address: Sean Morrison, Children’s
Austin Smith talk at ISSCR 2016: a ground state inhibitor pathway Read More »
Starting tomorrow I’m going to be at the ISSCR 2016 meeting live blogging it in San Francisco. The annual ISSCR meeting is a great place to hear about all the latest research from basic findings to reports on pre-clinical and clinical studies. There are always valuable and unique insights from chatting with people too. I
Live Blogging ISSCR 2016 SFO Read More »
I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the
ISSCR President Sean Morrison on challenges and future of stem cell field Read More »
ISSCR Chat By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was
Michael Cea ISSCR chat with Jeanne Loring on stem cell field Read More »